» Articles » PMID: 27706263

Gene-Activated Titanium Surfaces Promote In Vitro Osteogenesis

Overview
Specialty Dentistry
Date 2016 Oct 6
PMID 27706263
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Commercially pure titanium (CpTi) and its alloys possess favorable mechanical and biologic properties for use as implants in orthopedics and dentistry. However, failures in osseointegration still exist and are common in select individuals with risk factors such as smoking. Therefore, in this study, a proposal was made to enhance the potential for osseointegration of CpTi discs by coating their surfaces with nanoplexes comprising polyethylenimine (PEI) and plasmid DNA (pDNA) encoding bone morphogenetic protein-2 (pBMP-2).

Materials And Methods: The nanoplexes were characterized for size and surface charge with a range of N/P ratios (the molar ratio of amine groups of PEI to phosphate groups in pDNA backbone). CpTi discs were surface characterized for morphology and composition before and after nanoplex coating using scanning electron microscopy (SEM), atomic force microscopy (AFM), X-ray photoelectron spectroscopy (XPS), and X-ray powder diffraction (XRD). The cytotoxicity and transfection ability of CpTi discs coated with nanoplexes of varying N/P ratios in human bone marrow-derived mesenchymal stem cells (BMSCs) was measured via MTS assays and flow cytometry, respectively.

Results: The CpTi discs coated with nanoplexes prepared at an N/P ratio of 10 (N/P-10) were considered optimal, resulting in 75% cell viability and 14% transfection efficiency. Enzyme-linked immunosorbent assay results demonstrated a significant enhancement in BMP-2 protein secretion by BMSCs 7 days posttreatment with PEI/pBMP-2 nanoplexes (N/P-10) compared to the controls, and real-time PCR data demonstrated that the BMSCs treated with PEI/pBMP-2 nanoplex-coated CpTi discs resulted in an enhancement of Runx-2, alkaline phosphatase, and osteocalcin gene expressions on day 7 posttreatment. In addition, these BMSCs demonstrated enhanced calcium deposition on day 30 posttreatment as determined by qualitative (alizarin red staining) and quantitative (atomic absorption spectroscopy) assays.

Conclusion: It can be concluded that PEI/pBMP-2 nanoplex (N/P-10)-coated CpTi discs have the potential to induce osteogenesis and enhance osseointegration.

Citing Articles

Tissue-engineered bone construct promotes early osseointegration of implants with low primary stability in oversized osteotomy.

Xu L, Jacobs R, Cao Y, Sun X, Qin X BMC Oral Health. 2024; 24(1):69.

PMID: 38200461 PMC: 10782778. DOI: 10.1186/s12903-023-03834-x.


The clinical effect of ossotide for injection in the treatment of condylar fracture.

Jiang Q, Chen Y, Zhu F, Xie Y, Zhu Z, Sun X Indian J Pharmacol. 2024; 55(6):363-366.

PMID: 38174532 PMC: 10821697. DOI: 10.4103/ijp.ijp_157_23.


Fibrous topology promoted pBMP2-activated matrix on titanium implants boost osseointegration.

He T, Wang Y, Wang R, Yang H, Hu X, Pu Y Regen Biomater. 2024; 11:rbad111.

PMID: 38173764 PMC: 10761207. DOI: 10.1093/rb/rbad111.


Gene-Activated Materials in Regenerative Dentistry: Narrative Review of Technology and Study Results.

Krasilnikova O, Yakimova A, Ivanov S, Atiakshin D, Kostin A, Sosin D Int J Mol Sci. 2023; 24(22).

PMID: 38003439 PMC: 10671237. DOI: 10.3390/ijms242216250.


Application of Lyophilized Gene-Delivery Formulations to Dental Implant Surfaces: Non-Cariogenic Lyoprotectant Preserves Transfection Activity of Polyplexes Long-Term.

Malkawi W, Laird N, Phruttiwanichakun P, Mohamed E, Elangovan S, Salem A J Pharm Sci. 2022; 112(1):83-90.

PMID: 36372226 PMC: 9772140. DOI: 10.1016/j.xphs.2022.11.008.


References
1.
Gouveia C, Schultz J, Bianco A, Brent G . Thyroid hormone stimulation of osteocalcin gene expression in ROS 17/2.8 cells is mediated by transcriptional and post-transcriptional mechanisms. J Endocrinol. 2001; 170(3):667-75. DOI: 10.1677/joe.0.1700667. View

2.
Poynton A, Lane J . Safety profile for the clinical use of bone morphogenetic proteins in the spine. Spine (Phila Pa 1976). 2002; 27(16 Suppl 1):S40-8. DOI: 10.1097/00007632-200208151-00010. View

3.
Lo K, Ulery B, Ashe K, Laurencin C . Studies of bone morphogenetic protein-based surgical repair. Adv Drug Deliv Rev. 2012; 64(12):1277-91. PMC: 3401330. DOI: 10.1016/j.addr.2012.03.014. View

4.
Wang M . Developing bioactive composite materials for tissue replacement. Biomaterials. 2003; 24(13):2133-51. DOI: 10.1016/s0142-9612(03)00037-1. View

5.
Bjursten L, Rasmusson L, Oh S, Smith G, Brammer K, Jin S . Titanium dioxide nanotubes enhance bone bonding in vivo. J Biomed Mater Res A. 2009; 92(3):1218-24. DOI: 10.1002/jbm.a.32463. View